SELLAS Life Sciences Appoints Jane Wasman as Chair of Board of Directors
February 01, 2018 at 08:40 am EST
Women In Bio announced that Jane Wasman, President, International and General Counsel of Acorda Therapeutics, has been appointed as Chair of the Board of Directors of Sellas Life Sciences. As President, International and General Counsel at Acorda Therapeutics, Ms. Wasman leads long-range planning and development in addition to international expansion. In this role, she collaborates with senior leadership on commercialization, licensing/M&A strategy and implementation, investor relations, product pipeline development and government affairs activities.